PatientsVille.com Logo

Microgynon Side Effects

PatientsVille

Common Microgynon Side Effects


The most commonly reported Microgynon side effects (click to view or check a box to report):

Maternal Exposure During Pregnancy (3)
Musculoskeletal Stiffness (3)
Abortion Induced (3)
Haematoma (3)
Erythema (3)
Placental Disorder (3)
Lupus-like Syndrome (3)
Pregnancy (3)
Skin Lesion (3)
Swelling (3)
Rash (3)
Rash Erythematous (3)
Gastrointestinal Carcinoma (2)
Eye Infection (2)
Eye Disorder (2)
Liver Disorder (2)
Surgery (2)
Pain (2)
Thrombosis (2)
Toxoplasmosis (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Microgynon Side Effects Reported to FDA



Microgynon Side Effect Report#9251134
Deep Vein Thrombosis
This is a report of a 46-year-old female patient (weight: NA) from NL, suffering from the following health symptoms/conditions: contraception, who was treated with Microgynon 30 (dosage: Unk, start time: 200301), combined with: NA. and developed a serious reaction and side effect(s): Deep Vein Thrombosis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Microgynon 30 treatment in female patients, resulting in Deep Vein Thrombosis side effect.
Microgynon Side Effect Report#8907965
Amenorrhoea, Abdominal Distension, Dysmenorrhoea, Irritability, Withdrawal Syndrome
This report suggests a potential Microgynon Amenorrhoea side effect(s) that can have serious consequences. A 28-year-old female patient (weight: NA) from GB was diagnosed with the following symptoms/conditions: contraception and used Microgynon (dosage: Unk) starting 201205. After starting Microgynon the patient began experiencing various side effects, including: Amenorrhoea, Abdominal Distension, Dysmenorrhoea, Irritability, Withdrawal SyndromeAdditional drugs used concurrently:
  • Yasmin, Film-coated Tablets, 0.03 Mg/3 Mg (Unk)
Although Microgynon demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Amenorrhoea, may still occur.
Microgynon Side Effect Report#8075627-9
Abortion Induced, Placental Disorder, Pregnancy, Haematoma
This Abortion Induced problem was reported by a health professional from . A 20-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Dec 01, 2006 this consumer started treatment with Microgynon (eugynon /00022701/) (dosage: NA). The following drugs were being taken at the same time:
  • Lamotrigine (200 Mg (100 Mg,2 In 1 D),oral)
  • Folic Acid
When using Microgynon (eugynon /00022701/), the patient experienced the following unwanted symptoms/side effects: Abortion Induced, Placental Disorder, Pregnancy, HaematomaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Abortion Induced, may become evident only after a product is in use by the general population.
Microgynon Side Effect Report#8065494-1
Maternal Exposure During Pregnancy, Abortion Induced, Placental Disorder, Haematoma, Pregnancy
This Maternal Exposure During Pregnancy side effect was reported by a health professional from United Kingdom. A 20-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Microgynon (eugynon /00022701/) (drug dosage: NA), which was initiated on
Dec 01, 2006. Concurrently used drugs:
  • Lamotrigine (100 Mg, 2 In 1 D, Oral)
  • Folic Acid
.After starting to take Microgynon (eugynon /00022701/) the consumer reported adverse symptoms, such as: Maternal Exposure During Pregnancy, Abortion Induced, Placental Disorder, Haematoma, PregnancyThese side effects may potentially be related to Microgynon (eugynon /00022701/).
Microgynon Side Effect Report#8062275-X
Abortion Induced, Pregnancy, Haematoma, Placental Disorder, Maternal Exposure During Pregnancy
This is a report of a 20-year-old female patient (weight: NA) from , suffering from the following health symptoms/conditions: NA, who was treated with Microgynon (eugynon / /2007 - /00022701/) (dosage: NA, start time:
Dec 01, 2006), combined with:
  • Lamotrigine (200 Mg (100 Mg, 2 In 1 D), Oral)
  • Folic Acid
and developed a serious reaction and side effect(s): Abortion Induced, Pregnancy, Haematoma, Placental Disorder, Maternal Exposure During Pregnancy after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Microgynon (eugynon / /2007 - /00022701/) treatment in female patients, resulting in Abortion Induced side effect.
Microgynon Side Effect Report#7948388-9
Maternal Exposure During Pregnancy, Nausea, Pregnancy On Oral Contraceptive, Abortion Spontaneous
This report suggests a potential Microgynon 30 (ethinylestradiol, Levonorgestrel) (ethinylestradiol, Le Maternal Exposure During Pregnancy side effect(s) that can have serious consequences. A 22-year-old female patient (weight: NA) from Netherlands was diagnosed with the following symptoms/conditions: oral contraception and used Microgynon 30 (ethinylestradiol, Levonorgestrel) (ethinylestradiol, Le (dosage: NA) starting
Jan 01, 2010. After starting Microgynon 30 (ethinylestradiol, Levonorgestrel) (ethinylestradiol, Le the patient began experiencing various side effects, including: Maternal Exposure During Pregnancy, Nausea, Pregnancy On Oral Contraceptive, Abortion SpontaneousAdditional drugs used concurrently:
  • Atorvastatine (atorvastatin) (atorvastatin)
  • Colesevelam (colesevelam) (625 Milligram, Tablet) (colesevelan) (3750 Mg, Per Oral ; 3125 Mg,per Oral)
  • Colesevelam (colesevelam) (625 Milligram, Tablet) (colesevelan) (3750 Mg, Per Oral ; 3125 Mg,per Oral)
  • Ezetimibe
Although Microgynon 30 (ethinylestradiol, Levonorgestrel) (ethinylestradiol, Le demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Maternal Exposure During Pregnancy, may still occur.
Microgynon Side Effect Report#7504924-8
Appendiceal Abscess
This Appendiceal Abscess problem was reported by a physician from Australia. A 34-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: contraception,multiple sclerosis. On
Mar 01, 2008 this consumer started treatment with Microgynon 30 (dosage: NA). The following drugs were being taken at the same time:
  • Avonex
When using Microgynon 30, the patient experienced the following unwanted symptoms/side effects: Appendiceal AbscessThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Appendiceal Abscess, may become evident only after a product is in use by the general population.
Microgynon Side Effect Report#7473844-X
Alcohol Use, Completed Suicide
This Alcohol Use side effect was reported by a health professional from United Kingdom. A 17-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Microgynon /00022701/ (drug dosage: NA), which was initiated on
Jan 19, 2011. Concurrently used drugs:
  • Nexplanon (etonogestrel / 01502301/) (68 Mg, Sbde)
  • Lidocaine
.After starting to take Microgynon /00022701/ the consumer reported adverse symptoms, such as: Alcohol Use, Completed SuicideThese side effects may potentially be related to Microgynon /00022701/.
Microgynon Side Effect Report#5728214-9
Arthralgia, Erythema, Lupus-like Syndrome, Musculoskeletal Stiffness, Rash, Rash Erythematous, Skin Lesion, Swelling
This is a report of a 32-year-old female patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: contraception,insomnia,depression,osteopenia,fatigue, who was treated with Microgynon (dosage: NA, start time:
Feb 01, 2006), combined with:
  • Nifedipine
  • Amitriptline Hcl
  • Calcichew
  • Provigil
  • Provigil
  • Provigil
  • Multi-vitamin
and developed a serious reaction and side effect(s): Arthralgia, Erythema, Lupus-like Syndrome, Musculoskeletal Stiffness, Rash, Rash Erythematous, Skin Lesion, Swelling after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Microgynon treatment in female patients, resulting in Arthralgia side effect.
Microgynon Side Effect Report#5687680-8
Erythema, Lupus-like Syndrome, Musculoskeletal Stiffness, Pain, Rash, Rash Erythematous, Skin Lesion, Swelling
This report suggests a potential Microgynon Erythema side effect(s) that can have serious consequences. A 31-year-old female patient (weight: NA) from United Kingdom was diagnosed with the following symptoms/conditions: contraception,insomnia,depression,osteopenia,fatigue and used Microgynon (dosage: NA) starting
Feb 01, 2005. After starting Microgynon the patient began experiencing various side effects, including: Erythema, Lupus-like Syndrome, Musculoskeletal Stiffness, Pain, Rash, Rash Erythematous, Skin Lesion, SwellingAdditional drugs used concurrently:
  • Nifedipine
  • Amitriptyline Hcl
  • Calcichew
  • Provigil
Although Microgynon demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Erythema, may still occur.
Microgynon Side Effect Report#5675064-8
Erythema, Lupus-like Syndrome, Musculoskeletal Stiffness, Pain, Rash, Rash Erythematous, Skin Lesion, Swelling
This Erythema problem was reported by a health professional from United Kingdom. A 31-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: contraception,insomnia,depression,osteopenia,fatigue. On
Feb 01, 2005 this consumer started treatment with Microgynon (dosage: NA). The following drugs were being taken at the same time:
  • Nifedipine
  • Amitriptyline Hcl
  • Calcichew
  • Provigil
When using Microgynon, the patient experienced the following unwanted symptoms/side effects: Erythema, Lupus-like Syndrome, Musculoskeletal Stiffness, Pain, Rash, Rash Erythematous, Skin Lesion, SwellingAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Erythema, may become evident only after a product is in use by the general population.
Microgynon Side Effect Report#5599798-9
Eye Disorder, Eye Infection, Thrombosis, Toxoplasmosis
This Eye Disorder side effect was reported by a consumer or non-health professional from United Kingdom. A 21-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Microgynon 30 (21) (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Microgynon 30 (21) the consumer reported adverse symptoms, such as: Eye Disorder, Eye Infection, Thrombosis, ToxoplasmosisThese side effects may potentially be related to Microgynon 30 (21). The patient was hospitalized.
Microgynon Side Effect Report#5572317-9
Eye Disorder, Eye Infection, Thrombosis, Toxoplasmosis
This is a report of a 21-year-old female patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: NA, who was treated with Microgynon 30 (21) (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Eye Disorder, Eye Infection, Thrombosis, Toxoplasmosis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Microgynon 30 (21) treatment in female patients, resulting in Eye Disorder side effect. The patient was hospitalized.
Microgynon Side Effect Report#5106165-0
Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gastrointestinal Carcinoma, Liver Disorder, Surgery
This report suggests a potential Microgynon Alanine Aminotransferase Increased side effect(s) that can have serious consequences. A 50-year-old female patient (weight: NA) from Belgium was diagnosed with the following symptoms/conditions: NA and used Microgynon (dosage: NA) starting
Nov 07, 2005. After starting Microgynon the patient began experiencing various side effects, including: Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gastrointestinal Carcinoma, Liver Disorder, SurgeryAdditional drugs used concurrently:
  • Bisoprolol Fumarate W/hydrochlorothiazide
  • Lamisil (250 Mg/d)
Although Microgynon demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Alanine Aminotransferase Increased, may still occur.
Microgynon Side Effect Report#5105330-6
Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gastrointestinal Carcinoma, Liver Disorder, Surgery
This Alanine Aminotransferase Increased problem was reported by a physician from Belgium. A 50-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Nov 07, 2005 this consumer started treatment with Microgynon (dosage: NA). The following drugs were being taken at the same time:
  • Bisoprolol Fumarate W/hydrochlorothiazide
  • Lamisil (250 Mg/d)
When using Microgynon, the patient experienced the following unwanted symptoms/side effects: Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gastrointestinal Carcinoma, Liver Disorder, SurgeryAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Alanine Aminotransferase Increased, may become evident only after a product is in use by the general population.
Microgynon Side Effect Report#4998667-2
Antiphospholipid Antibodies Positive, Cardiolipin Antibody Positive, Mesenteric Artery Thrombosis, Portal Vein Thrombosis
This Antiphospholipid Antibodies Positive side effect was reported by a consumer or non-health professional from Spain. A 35-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Microgynon (21) (ethinylestradiol, Levonorgestrel) Coated Tablet (drug dosage: 1 Tab (s), Oral), which was initiated on
Dec 01, 2005. Concurrently used drugs: NA..After starting to take Microgynon (21) (ethinylestradiol, Levonorgestrel) Coated Tablet the consumer reported adverse symptoms, such as: Antiphospholipid Antibodies Positive, Cardiolipin Antibody Positive, Mesenteric Artery Thrombosis, Portal Vein ThrombosisThese side effects may potentially be related to Microgynon (21) (ethinylestradiol, Levonorgestrel) Coated Tablet.



The appearance of Microgynon on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.


What are common Microgynon Side Effects for Men?

Men Side EffectsReports

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Microgynon reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Microgynon Side Effects

    Did You Have a Microgynon Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Microgynon for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective